Pamela Silver, PhD
Elliott T. and Onie H. Adams Professor of Biochemistry and Systems Biology, Harvard Medical School
7The yeast mRNA-binding protein Npl3p interacts with the cap-binding complex.
Authors: Authors: Shen EC, Stage-Zimmermann T, Chui P, Silver PA.
J Biol Chem
View full abstract on Pubmed
J Biol Chem
View full abstract on Pubmed
Arginine methylation and binding of Hrp1p to the efficiency element for mRNA 3'-end formation.
Nuclear protein import is decreased by engineered mutants of nuclear transport factor 2 (NTF2) that do not bind GDP-Ran.
Authors: Authors: Clarkson WD, Corbett AH, Paschal BM, Kent HM, McCoy AJ, Gerace L, Silver PA, Stewart M.
J Mol Biol
View full abstract on Pubmed
J Mol Biol
View full abstract on Pubmed
Potential RNA binding proteins in Saccharomyces cerevisiae identified as suppressors of temperature-sensitive mutations in NPL3.
Nucleocytoplasmic traffic of proteins.
Analysis of M13 procoat assembly into membranes in vitro.
Authors: Authors: Watts C, Goodman JM, Silver P, Wickner W.
Methods Enzymol
View full abstract on Pubmed
Methods Enzymol
View full abstract on Pubmed
Bacterial variability in the mammalian gut captured by a single-cell synthetic oscillator.
Authors: Authors: Riglar DT, Richmond DL, Potvin-Trottier L, Verdegaal AA, Naydich AD, Bakshi S, Leoncini E, Lyon LG, Paulsson J, Silver PA.
Nat Commun
View full abstract on Pubmed
Nat Commun
View full abstract on Pubmed
Engineering bacteria for diagnostic and therapeutic applications.
A Catalytic Nanoreactor Based on in Vivo Encapsulation of Multiple Enzymes in an Engineered Protein Nanocompartment.
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors.